Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBT vs PBE overlap: 43% of top holdings shared

Bottom line

How much do FBT and PBE overlap?

43% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 45.8% of FBT's assets and 49.3% of PBE's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FBTPBE
Weight overlap (top 25)43%
Shared holdings14
Weight in shared holdings45.8%49.3%
Total positions3233
Expense ratio0.55%0.59%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings FBT and PBE have in common

Holding% of FBT% of PBEOverlap
Veracyte Inc VCYT5.10%2.60%2.60%
Illumina Inc ILMN3.92%3.51%3.51%
Neurocrine Biosciences Inc NBIX3.53%2.66%2.66%
Bio-techne Corp TECH3.43%3.73%3.43%
Biogen Inc BIIB3.37%4.79%3.37%
Exelixis Inc EXEL3.32%2.64%2.64%
Incyte Corp INCY3.18%3.06%3.06%
Halozyme Therapeutics Inc HALO3.11%2.98%2.98%
Vertex Pharmaceuticals Inc VRTX3.07%4.99%3.07%
Repligen Corp RGEN3.07%3.04%3.04%
Biomarin Pharmaceutical Inc BMRN2.83%2.82%2.82%
Amgen Inc AMGN2.78%5.22%2.78%
United Therapeutics Corp UTHR2.56%4.08%2.56%
Alnylam Pharmaceuticals Inc ALNY2.52%3.17%2.52%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBT

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Bruker Corp — 4.32%
  4. Alkermes Plc — 4.24%
  5. Krystal Biotech Inc — 3.87%
  6. Natera Inc — 3.79%
  7. Axsome Therapeutics Inc — 3.71%
  8. Arrowhead Pharmaceuticals Inc — 3.38%
  9. Argenx Se — 3.13%
  10. Biontech Se — 2.63%
  11. Genmab A/s — 2.62%

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. CareDx, Inc. — 5.04%
  4. Invesco Private Government Fund — 4.97%
  5. Royalty Pharma PLC — 4.94%
  6. Gilead Sciences, Inc. — 4.43%
  7. Protagonist Therapeutics, Inc. — 3.40%
  8. Vericel Corp. — 3.27%
  9. Acadia Pharmaceuticals Inc. — 3.02%
  10. Qiagen N.V. — 2.89%
  11. BioCryst Pharmaceuticals, Inc. — 2.63%

Asset mix

Asset typeFBTPBE
Stocks100.0%100.1%
Cash & short-term funds0.1%17.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryFBTPBE
US85.0%108.6%
GB—4.9%
IE4.2%—
NL3.1%2.9%
DE2.6%—
DK2.6%—
CH2.5%—
KY—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FBT and PBE overlap?
About 43% by weight. 14 securities appear in both funds' top 25 holdings; they make up 45.8% of FBT's assets and 49.3% of PBE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBT and PBE have in common?
The largest shared holdings are Illumina Inc, Bio-techne Corp, Biogen Inc, Vertex Pharmaceuticals Inc, Incyte Corp.
Should I own both FBT and PBE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBT or PBE?
PBE is broader, with 33 positions versus 32 for FBT. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.